 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | LCAR-B4822M CAR-T cell therapy / Legend Biotech
Enrollment closed: LCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma (clinicaltrials.gov) - Dec 14, 2018
P1, N=10, Active, not recruiting, Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University
Recruiting --> Active, not recruiting
- | LCAR-B4822M CAR-T cell therapy / Legend Biotech
New P1 trial: LCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma (clinicaltrials.gov) - Sep 16, 2018
P1, N=10, Recruiting, Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University